ロード中...
Improved Clearance during Treatment of HPV-Positive Head and Neck Cancer through mTOR Inhibition
Human papillomavirus (HPV)-related head and neck squamous cell carcinoma (HNSCC) incidence is increasing at a near epidemic rate. We investigated whether the mammalian (or mechanistic) target of rapamycin (mTOR) inhibitor, rapamycin, can be used as a concurrent agent to standard-of-care cisplatin/ra...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Neoplasia Press Inc.
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3664994/ https://ncbi.nlm.nih.gov/pubmed/23730210 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|